Emerging Technology

Myomo's MyoPro 2x revolutionizes upper-limb paralysis treatment, enhancing independence with advanced myoelectric orthoses for improved user experience and clinical outcomes.

Results show that the system consistently achieves high stone-clearance rates across diverse patient populations and clinical settings—key factors in reducing repeat procedures.

CorWave advances heart failure treatment with a groundbreaking LVAD, showcasing promising preclinical results and paving the way for human trials.

MIT's CircTrek device revolutionizes health monitoring by detecting individual cells in real-time, promising personalized treatments and improved patient outcomes.

Ohio State researchers develop system that analyzes health by how they walk

Robotic removal of blood clots could dramatically change stroke care

Adagio Medical Receives FDA Breakthrough Device Designation for its Cryoablation System that targets VT

Device can now be used in patients with symptomatic moderate-to-severe or severe mitral regurgitation who are not candidates for surgery or transcatheter edge-to-edge repair therapy.

RSP Systems achieves major milestone in non-invasive glucose monitoring technology

Oak Orchard Health taps AI tools from eClinicalWorks to boost efficiency, patient care

Predictmedix cites growing role in health and safety for its device’s success

The company also expects to submit its application for 510(k) clearance for its OneRF Trigeminal Nerve Ablation System in May, sooner than expected.

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.

Omid Veiseh, PhD, faculty director of the Rice Biotech Launchpad, discusses his organization’s mission to create innovative biotechnology based on patient need.

FDA approves Dawes-Redman CTG analysis for U.S. use, enhancing fetal monitoring

Triage solution is built on existing AI engine

Autonomous solution doesn’t require dilation in vast majority of cases

A market analysis report from Grand View Research projects the AI diagnostics market size to grow at a CAGR of 24.60% through 2030.